r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SO

Stephanie Okey

Insider · Director · CRNX

Stephanie Okey files insider transactions with the SEC as a director of Crinetics Pharmaceuticals (CRNX). We hold 4 disclosed purchases and sales filed since 11 June 2018, 1 of them in the last 90 days.

  • Files forCRNX
  • Disclosed buys and sells4 in all, 1 in the last 90 days
  • Last disclosure1 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 July 2019 — 1 September 2026Director · Crinetics Pharmaceuticals (CRNX)28 Form 4 lines · source: SEC Form 4
  • Filed 14 December 2018 — 10 March 2026Director · Ptc Therapeutics (PTCT)38 Form 4 lines · source: SEC Form 4
  • Filed 28 August 2023 — 18 December 2024Director · Catalent (CTLT)4 Form 4 lines · source: SEC Form 4
  • Filed 8 June 2018 — 2 March 2023Director · Albireo Pharma (ALBO)12 Form 4 lines · source: SEC Form 4

Everything they disclosed

82 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.